SCHEMBL10212149

SCHEMBL10212149

Cc1cccc(NC(=O)c2ccc(-c3ccccc3)cc2)c1N

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.62
RAB9A P51151 2/20 0.62
HPGD P15428 2/20 0.59
POLB P06746 2/20 0.59
PDCD1 Q15116 1/20 0.58
CD274 Q9NZQ7 1/20 0.58
DHODH Q02127 1/20 0.57
KMT2A Q03164 3/20 0.57
MEN1 O00255 2/20 0.57
MAPT P10636 2/20 0.57
LMNA P02545 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
HDAC1 Q13547 6/20 0.55
HDAC2 Q92769 6/20 0.55
HDAC3 O15379 3/20 0.55
MAPK1 P28482 2/20 0.53
GRM5 P41594 1/20 0.52
ALDH1A1 P00352 1/20 0.52
CYP1A2 P05177 1/20 0.51
CYP2C9 P11712 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15290422 0.86 HPGD (0.80) NPC1RAB9AHPGDPOLBPDCD1
SCHEMBL505634 0.81 PDCD1 (0.60) NPC1RAB9AHPGDPOLBPDCD1
SCHEMBL11911355 0.78 MAPT (0.65) NPC1RAB9AHPGDPOLBPDCD1
SCHEMBL7264464 0.78 POLB (0.77) NPC1RAB9AHPGDPOLBKMT2A
SCHEMBL19337640 0.78 NPC1 (0.72) NPC1RAB9AHPGDPOLBPDCD1
SCHEMBL9055150 0.77 HPGD (0.89) NPC1RAB9AHPGDPOLBKMT2A
SCHEMBL683706 0.76 POLB (0.74) NPC1RAB9AHPGDPOLBKMT2A
SCHEMBL23735897 0.76 HDAC1 (0.50) NPC1RAB9AHPGDPOLBPDCD1
SCHEMBL13390269 0.76 HDAC2 (0.76) NPC1RAB9APOLBKMT2AMEN1
SCHEMBL1060598 0.76 HDAC1 (0.79) NPC1RAB9APDCD1CD274DHODH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9006454-B2 Dihydroorotate dehydrogenase inhibitors MERCK SERONO S.A. (CH) 2015-04-14 US disclosed
US-20120028959-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS MERCK SERONO S.A. (CH) 2012-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120028959-A1 DIHYDROOROTATE DEHYDROGENASE INHIBITORS DHODH, FH, DPYD NPC1 3171/4885RAB9A 1436/4885HPGD 179/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.